Historically, sickle cell anaemia has been widely neglected within its global epicentre of sub-Saharan Africa. More than ...

The new gene therapies for sickle cell disease—including the gene-editing treatment Casgevy, based on research at Boston ...

The hospital faces challenges of blood shortages, space constraints, and community awareness gaps in managing sickle cell ...

The scene is cloaked in thick darkness. A crowd enthusiastically counts down. “3…2…1!” Bright resplendent light bursts forth! A Christmas tree and surrounding decorations shine with gleaming vivid ...

Dear Dr. Roach: I read your recent column on shingles. I am 66 years old and in fairly good health. I had both Shingrix shots ...

The revenue for Povorcitinib is expected to reach an annual total of $91 mn by 2035 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to ...

Children who received a stem cell transplant for sickle cell disease (SCD) experienced better quality of life outcomes and cognitive perfo ...

I have a serious problem with my fingernails splitting and coming off at the edges. I have tried biotin and keratin for almost a year without results.

I read your recent column on shingles. I am 66 years old and in fairly good health. I had both Shingrix shots about five years ago. I take hydroxyurea for polycythemia vera (PV). Around Aug. 1, I ...

Fedratinib can reduce symptoms and spleen volume in patients with myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), according to research presented at the ASH Annual Meeting 2024.

SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in ...

INCY's phase III study, evaluating retifanlimab in combination with platinum-based chemotherapy for the treatment of metastatic non-small cell lung cancer, meets primary and secondary endpoints.